ATE260115T1 - Reduzierte fett-absorption durch anti-lipase antikörper - Google Patents

Reduzierte fett-absorption durch anti-lipase antikörper

Info

Publication number
ATE260115T1
ATE260115T1 AT98932392T AT98932392T ATE260115T1 AT E260115 T1 ATE260115 T1 AT E260115T1 AT 98932392 T AT98932392 T AT 98932392T AT 98932392 T AT98932392 T AT 98932392T AT E260115 T1 ATE260115 T1 AT E260115T1
Authority
AT
Austria
Prior art keywords
fat absorption
reduced fat
lipase antibodies
lipase
antibodies
Prior art date
Application number
AT98932392T
Other languages
English (en)
Inventor
Julio L Pimentel
Original Assignee
Ximed Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ximed Group Plc filed Critical Ximed Group Plc
Application granted granted Critical
Publication of ATE260115T1 publication Critical patent/ATE260115T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT98932392T 1997-07-07 1998-07-06 Reduzierte fett-absorption durch anti-lipase antikörper ATE260115T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/888,202 US7344713B1 (en) 1997-07-07 1997-07-07 Decreased fat absorption with an anti-lipase antibody
PCT/GB1998/001998 WO1999002187A2 (en) 1997-07-07 1998-07-06 Decreased fat absorption with an anti-lipase antibody

Publications (1)

Publication Number Publication Date
ATE260115T1 true ATE260115T1 (de) 2004-03-15

Family

ID=25392734

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98932392T ATE260115T1 (de) 1997-07-07 1998-07-06 Reduzierte fett-absorption durch anti-lipase antikörper

Country Status (14)

Country Link
US (1) US7344713B1 (de)
EP (1) EP1001809B1 (de)
JP (1) JP2001525314A (de)
CN (1) CN1269728A (de)
AT (1) ATE260115T1 (de)
AU (1) AU8232698A (de)
BG (1) BG104061A (de)
BR (1) BR9815504A (de)
CA (1) CA2295735A1 (de)
DE (1) DE69821946D1 (de)
HU (1) HUP0002753A2 (de)
IL (1) IL133881A0 (de)
TR (1) TR200000002T2 (de)
WO (1) WO1999002187A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618624B1 (en) * 1999-01-07 2009-11-17 Anitox Corporation Weight control using an anti-lipase antibody
US20040018197A1 (en) * 2002-04-26 2004-01-29 Promega Corporation Treatment for weight loss
GB2389362B (en) * 2002-06-05 2006-02-15 Walcom Animal Science Antibodies to adipose tissues
TW200507861A (en) * 2003-04-10 2005-03-01 Ghen Corp Antiobesity agent using hen-egg antibody against digestive enzyme
WO2008013455A1 (en) * 2006-07-27 2008-01-31 Lactive B.V. Means and methods for preventing elevated blood glucose levels in humans with animal antibodies produced in milk
US10053516B2 (en) * 2013-12-02 2018-08-21 Ostrich Pharma Kk Method for manufacturing digestive enzyme antibody and egg having same, and for manufacturing processed product containing egg as ingredient thereof and composition including antibody
US10538593B2 (en) 2013-12-02 2020-01-21 Ostrich Pharma Kk Method for manufacturing digestive enzyme antibody and egg having same, and for manufacturing processed product containing egg as ingredient thereof and composition including antibody
JP6872841B2 (ja) * 2014-04-28 2021-05-19 アサマ化成株式会社 脂肪低減組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CH0225254H1 (en) * 1985-11-25 1998-09-15 Ghen Corp Specific antibody-containing substance from eggs and method of production and use thereof
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
JPH0745520B2 (ja) * 1988-08-31 1995-05-17 国際試薬株式会社 モノクローナル抗体およびその使用法
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
US5585098A (en) * 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants

Also Published As

Publication number Publication date
WO1999002187A2 (en) 1999-01-21
BR9815504A (pt) 2000-11-28
JP2001525314A (ja) 2001-12-11
EP1001809A1 (de) 2000-05-24
HUP0002753A2 (hu) 2000-12-28
BG104061A (en) 2000-11-30
CN1269728A (zh) 2000-10-11
WO1999002187A3 (en) 2001-06-07
US7344713B1 (en) 2008-03-18
EP1001809B1 (de) 2004-02-25
DE69821946D1 (de) 2004-04-01
TR200000002T2 (tr) 2000-09-21
CA2295735A1 (en) 1999-01-21
IL133881A0 (en) 2001-04-30
AU8232698A (en) 1999-02-08

Similar Documents

Publication Publication Date Title
CA2198958A1 (en) Method for amplification of the response signal in a sandwich immunoassay
BR9404242A (pt) Processo para a determinação de proteína e creatinina
PT996728E (pt) Anticorpos anti-ige melhorados e metodo para melhorar polipeptidos
WO2000031237A3 (en) Method of cloning porcine animals
NO981712D0 (no) Syntetisk diesel brennstoff, samt fremgangsmÕte ved fremstilling derav
FI962686L (fi) Fluorenssiin perustuva immunomääritysmenetelmä
NZ331299A (en) Antibody variants with reduced affinity for a cell-surface antigen
EP0037110A3 (en) Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
ES2124215T3 (es) Unos anticuerpos monoclonales al fiv y polipeptidos relacionados y su metodo de obtencion.
BR9710450A (pt) Anticorpo passivamente administrado que intensifica a eficiencia de conversÆo de alimenta-Æo
GB9613207D0 (en) Method for quantitative measurement of an enzyme linked immunosorbent assay
DE59509344D1 (de) Antikörperklassenspezifisches entstörungsreagenz
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
DE69821946D1 (de) Reduzierte fett-absorption durch anti-lipase antikörper
DE69818388D1 (en) Immunoassay für spongiforme encephalopathien
EP1072888A3 (de) Immunoassay-Verfahren und -Reagens für HIV-1p24-Antigen
DE69732034D1 (de) Assay-verfahren
DK0709455T3 (da) Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an
FI883778A7 (fi) Tyyppiä III olevan prokollageenin propeptidin vasta-aine ja määritysenetelmä, jossa sitä käytetään.
AU2696495A (en) Method for determining hiv-1 antigen and antibody
ES2171639T3 (es) Procedimiento de valoracion inmunologica del cortisol, principalmente el contenido en la orina, y reactivos utilizados.
WO1999024835A3 (en) An immunoassay for procollagen-iii-c-terminal propeptide
PT672756E (pt) Anticorpo monoclonal que reconhece a proteina de ligacao a fk506 processo de doseamento do nivel de proteina de ligaca a fk506 e "kit" para doseamento
ES8606500A1 (es) Un metodo para determinar la presencia de ige especifica en sueros humanos
DE60024521D1 (de) Homogenes Enzym-Immunoassay- Verfahren mit zweitem Antikörper

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties